Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00 at Wells Fargo & Company

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target hoisted by equities researchers at Wells Fargo & Company from $21.00 to $22.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 10.57% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the company. Weiss Ratings upgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Wednesday, March 18th. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. UBS Group increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, February 19th. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Finally, Scotiabank upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.00.

Sabra Healthcare REIT Stock Up 0.3%

NASDAQ:SBRA traded up $0.06 during midday trading on Thursday, reaching $19.90. 279,672 shares of the stock traded hands, compared to its average volume of 2,778,421. The stock has a market capitalization of $5.02 billion, a PE ratio of 31.10, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. Sabra Healthcare REIT has a 12-month low of $15.75 and a 12-month high of $21.07. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29. The business has a 50-day moving average of $19.77 and a two-hundred day moving average of $19.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The firm had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same period in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Institutional Trading of Sabra Healthcare REIT

Large investors have recently made changes to their positions in the business. Cornerstone Wealth Management LLC lifted its holdings in shares of Sabra Healthcare REIT by 256.6% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares during the period. AlphaQuest LLC lifted its stake in shares of Sabra Healthcare REIT by 309.2% in the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after purchasing an additional 109,444 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its holdings in Sabra Healthcare REIT by 51.2% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after buying an additional 195,600 shares in the last quarter. Franklin Resources Inc. grew its position in Sabra Healthcare REIT by 27.4% during the second quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock valued at $9,285,000 after buying an additional 108,268 shares during the period. Finally, Allianz Asset Management GmbH increased its holdings in Sabra Healthcare REIT by 9.9% in the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after buying an additional 81,293 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.